Prices of injectable generic drugs are going up. Photo: BSIP/UIG via Getty Images
Pharmaceutical companies have raised the prices of 43 generic drugs by at least 10% so far in the first half of 2018, according to an analysis from the investment bank Barclays. About half of those drugs are injectable generics used in hospitals, like vancomycin hydrochloride and heparin sodium.
The bottom line: Drug makers aren't just hiking prices on brand-name products. The increases are pretty much across the board and include generics that have been around for decades.